PDE5A and cancer: The selective nature by which inhibitors suppress tumor cell growth also suggest the feasibility of targeting PDE5 and 10 for cancer drug discovery, although further studies are necessary to determine if there are efficacy or safety advantages in targeting specific isozymes.